Elevated uric acid levels promote hepatic steatosis by activating the NLRP3 inflammasome (31), while AST, reflecting mitochondrial dysfunction and hepatocyte injury, showed a positive association with SAF (β = 0.003), supporting its role as a marker of disease activity. The gene discussed is NLRP3; the disease is Hepatic steatosis.